Login to Your Account



Financings Roundup


Friday, April 29, 2011
Cell Therapeutics Inc., of Seattle, will sell approximately $16 million worth of shares of series 12 preferred stock and warrants to purchase shares of common stock in a registered offering to three of its institutional investors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription